Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response.
作者信息
Parikh Aparna R, Corcoran Ryan B
机构信息
Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, Massachusetts.
出版信息
Clin Cancer Res. 2021 Dec 1;27(23):6614-6615. doi: 10.1158/1078-0432.CCR-21-3306.
Abstract
摘要
相似文献
1
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Response.仅血浆循环肿瘤DNA指导的结直肠癌患者微小残留病检测——反应情况
Clin Cancer Res. 2021 Dec 1;27(23):6614-6615. doi: 10.1158/1078-0432.CCR-21-3306.
2
Plasma-only ctDNA-Guided MRD Detection in Patients with CRC-Letter.仅血浆循环肿瘤DNA指导的结直肠癌患者微小残留病检测——信函
Clin Cancer Res. 2021 Dec 1;27(23):6613. doi: 10.1158/1078-0432.CCR-21-2735.
3
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.循环肿瘤 DNA 在精准肿瘤学中的应用及其在结直肠癌中的应用。
Int J Mol Sci. 2022 Apr 18;23(8):4441. doi: 10.3390/ijms23084441.
4
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.循环肿瘤 DNA 深度测序检测分子残留病并预测胃癌复发。
Cell Death Dis. 2020 May 11;11(5):346. doi: 10.1038/s41419-020-2531-z.
5
Perioperative Dynamic Changes in Circulating Tumor DNA in Patients with Lung Cancer (DYNAMIC).肺癌患者围手术期循环肿瘤 DNA 的动态变化（DYNAMIC）。
Clin Cancer Res. 2019 Dec 1;25(23):7058-7067. doi: 10.1158/1078-0432.CCR-19-1213. Epub 2019 Aug 22.
6
Perioperative ctDNA-Based MRD Detection in NSCLC-Response.基于ctDNA的非小细胞肺癌围手术期微小残留病检测——反应情况
Clin Cancer Res. 2022 Aug 2;28(15):3401. doi: 10.1158/1078-0432.CCR-22-1226.
7
Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.循环肿瘤 DNA（ctDNA）在非小细胞肺癌中的作用研究。
Int J Mol Sci. 2022 Aug 12;23(16):9006. doi: 10.3390/ijms23169006.
8
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies.术后循环肿瘤 DNA 对非转移性结直肠癌的预后意义：三项队列研究的个体患者汇总分析。
Int J Cancer. 2021 Feb 15;148(4):1014-1026. doi: 10.1002/ijc.33312. Epub 2020 Oct 6.
9
Detection and Quantification of ctDNA for Longitudinal Monitoring of Treatment in Non-Small Cell Lung Cancer Patients Using a Universal Mutant Detection Assay by Denaturing Capillary Electrophoresis.使用变性毛细管电泳的通用突变检测分析对非小细胞肺癌患者进行治疗的纵向监测中的 ctDNA 的检测和定量。
Pathol Oncol Res. 2022 Jun 28;28:1610308. doi: 10.3389/pore.2022.1610308. eCollection 2022.
10
Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.早期非小细胞肺癌——ctDNA 筛查和 MRD 检测实施面临的挑战。
Nat Rev Clin Oncol. 2018 Sep;15(9):577-586. doi: 10.1038/s41571-018-0058-3.
引用本文的文献
1
Liquid Biopsy and Challenge of Assay Heterogeneity for Minimal Residual Disease Assessment in Colon Cancer Treatment.液体活检与结肠癌治疗中微小残留病评估的检测异质性挑战
Genes (Basel). 2025 Jan 9;16(1):71. doi: 10.3390/genes16010071.
2
Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis.循环肿瘤 DNA 作为结直肠癌根治性切除术患者（接受或不接受辅助化疗）微小残留病评估和复发风险的标志物：一项系统评价和荟萃分析。
Int J Mol Sci. 2023 Jun 16;24(12):10230. doi: 10.3390/ijms241210230.
3
Integrated analysis of circulating tumour cells and circulating tumour DNA to detect minimal residual disease in hepatocellular carcinoma.循环肿瘤细胞与循环肿瘤DNA的综合分析以检测肝细胞癌中的微小残留病
Clin Transl Med. 2022 Apr;12(4):e793. doi: 10.1002/ctm2.793.
本文引用的文献
1
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.利用仅血浆循环肿瘤 DNA 检测在结直肠癌患者中检测微小残留病灶。
Clin Cancer Res. 2021 Oct 15;27(20):5586-5594. doi: 10.1158/1078-0432.CCR-21-0410. Epub 2021 Apr 29.
2
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper.ctDNA 在结直肠癌中的应用及整合：NCI 结肠和直肠分析工作组白皮书。
Nat Rev Clin Oncol. 2020 Dec;17(12):757-770. doi: 10.1038/s41571-020-0392-0. Epub 2020 Jul 6.
3
Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.I至III期结直肠癌患者血浆游离DNA的深度测序分析
JAMA Oncol. 2019 Aug 1;5(8):1124-1131. doi: 10.1001/jamaoncol.2019.0528.
4
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.局部肺癌中循环肿瘤 DNA 谱分析的分子残留疾病的早期检测。
Cancer Discov. 2017 Dec;7(12):1394-1403. doi: 10.1158/2159-8290.CD-17-0716. Epub 2017 Sep 24.
5
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.循环肿瘤DNA分析可检测II期结肠癌患者的微小残留病并预测复发。
Sci Transl Med. 2016 Jul 6;8(346):346ra92. doi: 10.1126/scitranslmed.aaf6219.
6
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.循环肿瘤 DNA 中的突变追踪可预测早期乳腺癌的复发。
Sci Transl Med. 2015 Aug 26;7(302):302ra133. doi: 10.1126/scitranslmed.aab0021.
Zotero 插件